Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery

NCT03384836 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

47

Enrollment

OTHER

Sponsor class

Stopped interim Analysis

Conditions

Stage IIIC Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
DRUG: Propranolol Hydrochloride

Sponsor

Roswell Park Cancer Institute